Equities research analysts forecast that Scholar Rock Holding Corp (NASDAQ:SRRK) will post ($0.41) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Scholar Rock’s earnings, with the highest EPS estimate coming in at ($0.40) and the lowest estimate coming in at ($0.42). Scholar Rock posted earnings per share of ($1.39) in the same quarter last year, which would suggest a positive year over year growth rate of 70.5%. The company is expected to announce its next quarterly earnings report on Wednesday, August 14th.

According to Zacks, analysts expect that Scholar Rock will report full-year earnings of ($1.83) per share for the current year, with EPS estimates ranging from ($1.94) to ($1.64). For the next year, analysts anticipate that the firm will report earnings of ($2.27) per share, with EPS estimates ranging from ($2.94) to ($1.42). Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Scholar Rock.

Scholar Rock (NASDAQ:SRRK) last posted its earnings results on Tuesday, May 14th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.50) by $0.08. The business had revenue of $3.11 million during the quarter, compared to analyst estimates of $5.05 million.

A number of analysts have recently weighed in on SRRK shares. Zacks Investment Research cut shares of Scholar Rock from a “buy” rating to a “hold” rating in a research note on Thursday, February 21st. Wedbush restated an “outperform” rating and issued a $27.00 price objective on shares of Scholar Rock in a research note on Wednesday, May 15th. ValuEngine cut shares of Scholar Rock from a “buy” rating to a “hold” rating in a research note on Tuesday, June 4th. Finally, Cowen restated a “buy” rating on shares of Scholar Rock in a research note on Wednesday, February 27th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $27.25.

Institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp acquired a new stake in shares of Scholar Rock in the third quarter worth $351,000. Vanguard Group Inc lifted its stake in shares of Scholar Rock by 479.1% in the third quarter. Vanguard Group Inc now owns 231,656 shares of the company’s stock worth $5,966,000 after buying an additional 191,656 shares during the last quarter. New York State Common Retirement Fund acquired a new stake in shares of Scholar Rock in the fourth quarter worth $147,000. BB Biotech AG lifted its stake in shares of Scholar Rock by 573.8% in the fourth quarter. BB Biotech AG now owns 1,279,978 shares of the company’s stock worth $29,401,000 after buying an additional 1,090,021 shares during the last quarter. Finally, Teachers Advisors LLC acquired a new stake in shares of Scholar Rock in the third quarter worth $206,000. Institutional investors and hedge funds own 52.76% of the company’s stock.

Shares of Scholar Rock stock traded up $0.17 on Wednesday, reaching $17.49. The stock had a trading volume of 32,486 shares, compared to its average volume of 92,417. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.05. Scholar Rock has a fifty-two week low of $13.09 and a fifty-two week high of $30.00. The stock has a market capitalization of $454.30 million and a price-to-earnings ratio of -5.55.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, an inhibitor of the activation of myostatin, which is in Phase I clinical trials for the treatment of spinal muscular atrophy.

Featured Story: The mechanics of the bid-ask spread in trading

Get a free copy of the Zacks research report on Scholar Rock (SRRK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Scholar Rock (NASDAQ:SRRK)

Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.